4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001705477-26-000003
Chief Financial Officer sold 4,442 shares at $45.43 ($201,787)
- Chief Financial Officer acquired 10,937 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Nofi Michael · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-10 | Exercise or conversion : show line 1 in the form | +10,937 | 10,937 | D | ||
| 2026-11-10 | Sale : show line 2 in the form | −4,442 | $45.43 | $201,787 | 6,495 | D |
| Open-market sales · 4,442 sh · avg $45.43 · $201,787 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-10 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −10,937 | 32,813 | D |
Loading xslF345X06/primarydocument.xml…